Chemoinformaics analysis of 4-Methyl-Heptanedioic Acid
| Molecular Weight | 497.761 | nRot | 26 |
| Heavy Atom Molecular Weight | 442.321 | nRig | 3 |
| Exact Molecular Weight | 497.408 | nRing | 0 |
| Solubility: LogS | -3.189 | nHRing | 0 |
| Solubility: LogP | 8.134 | No. of Aliphatic Rings | 0 |
| Acid Count | 2 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 90 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 35 | No. of Aromatic Carbocycles | 0 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 55 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 29 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 90.2136 |
| nHD | 3 | BPOL | 58.3504 |
| QED | 0.105 |
| Synth | 2.483 |
| Natural Product Likeliness | 0.065 |
| NR-PPAR-gamma | 0.951 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0 |
| HIA | 0.01 |
| CACO-2 | -5.329 |
| MDCK | 0.0000248 |
| BBB | 0.001 |
| PPB | 0.975572 |
| VDSS | 0.729 |
| FU | 0.00449853 |
| CYP1A2-inh | 0.04 |
| CYP1A2-sub | 0.171 |
| CYP2c19-inh | 0.094 |
| CYP2c19-sub | 0.079 |
| CYP2c9-inh | 0.123 |
| CYP2c9-sub | 0.997 |
| CYP2d6-inh | 0.043 |
| CYP2d6-sub | 0.071 |
| CYP3a4-inh | 0.021 |
| CYP3a4-sub | 0.004 |
| CL | 1.385 |
| T12 | 0.675 |
| hERG | 0.036 |
| Ames | 0.003 |
| ROA | 0.003 |
| SkinSen | 0.799 |
| Carcinogencity | 0.115 |
| EI | 0.512 |
| Respiratory | 0.192 |
| NR-Aromatase | 0.014 |
| Antiviral | Yes |
| Prediction | 0.742452 |